Headlinne
Sign inGet Headlinne
Hacker News·3 min read·medium

FDA approves new kind of cholesterol pill

M
mgh2
FDA approves new kind of cholesterol pill
✦AI Summary

The FDA has approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor designed to lower LDL cholesterol in adults with hypercholesterolemia. This new medication offers an alternative to existing injectable PCSK9 therapies for patients who require additional cholesterol reduction.

Why it mattersUnlock →

First oral PCSK9 inhibitor provides an additional treatment option for adults with hypercholesterolemia

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthbusinessscience
Political bias analysisUnlock →
Read originalGet full access
✦

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in